Latin America - Brazil

Demarest Advogados

More informationMore information

The 'highly qualified and experienced team' at Demarest Advogados acts for domestic and international companies from the pharmaceutical, consumer goods, animal health, medicine, healthcare and biochemical industries. With a multidisciplinary approach, the practice is well positioned to handle the full array of life sciences mandates, including interactions with ANVISA. Showcasing notable strength in biotech work, Claudio Mattos is particularly skilled in regulatory matters involving bio-controlled substances and genetically modified organisms. Bruno Aurélio, a key contact for tobacco and healthcare companies, and senior associate Monique Guzzo, a name to note for the pharmaceutical, food and supplementary health segments, stand out for their regulatory and public law capabilities. Ana Paula Pinheiro Schedel is experienced in pharmaceutical and biotechnology contracts, while Camila Biral often handles high-profile disputes in this space.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Demarest stands out for its excellence, with a highly qualified and experienced team. The firm has implemented innovations including cutting-edge technology, collaborative teamwork and innovative tools, making it an excellent choice.’

  • ‘Monique Guzzo stands out for her high level of regulatory health knowledge, bringing solutions and clarification of key points for our business. She also has excellent organisational skills and is efficient in meeting demands.’

  • ‘What makes Demarest unique and different is the quality of the lawyers, transparency, and agility. It was able to welcome our company and make us feel safe.'

  • ‘I recommend this team to everyone, Monique Guzzo is fantastic for life sciences, and everyone has been great to work with.’

  • 'Claudio Mattos has great expertise in the contractual area.'

  • ‘The work provided by Demarest is very technical and objective as well as efficient.’

Key clients

  • Bayer
  • Neto
  • Hoya
  • Gelita do Brasil
  • JT International Distribuidora de Cigarros
  • DaVita Group: DaVita Tratamento Renal – Brasil and Davita do Brasil
  • Grupo DPSP – Drogaria São Paulo e Pacheco
  • Scheffer & Cia
  • Carl Zeiss do Brasil
  • Bacardi Martini do Brasil
  • W Dental
  • Lilly Med
  • WeFiv Clinic
  • Nouryon

Work highlights

  • Represented Bayer/ Monsanto in a public-interest lawsuit against the Brazilian Federal Government and the State of Rio Grande do Sul, in which the counterparties seek an order to prohibit the use of glyphosate in transgenic soy.
  • Represented Bayer/ Monsanto in several lawsuits filed by rural producers questioning the client's seeds' performance.
  • Advising Neto on regulatory matters related to medical device imports.

Practice head

The lawyer(s) leading their teams.

Bruno Aurélio, Claudio Mattos, Monique Guzzo